Viewing Study NCT05954468



Ignite Creation Date: 2024-05-06 @ 7:16 PM
Last Modification Date: 2024-10-26 @ 3:03 PM
Study NCT ID: NCT05954468
Status: COMPLETED
Last Update Posted: 2023-10-25
First Post: 2023-07-13

Brief Title: Psycho-social Impact of Anti-NMDAR Encephalitis
Sponsor: Hospices Civils de Lyon
Organization: Hospices Civils de Lyon

Study Overview

Official Title: Psycho-social Impact of Anti-NMDAR Encephalitis
Status: COMPLETED
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SAPIENCE
Brief Summary: NMDA receptor encephalitis is a rare neurological autoimmune disease with severe neuropsychiatric symptoms but a typically good functional neurological outcome The majority of patients experience long-term cognitive psychological and social impairments that have significant consequences for their well-being and quality of life However as the disease was only recently discovered Dalmau and al Annals of neurology 2007 this psycho-social impact has not been studied systematically and the resulting consequences for patients are not adequately appreciated

The proposed study aims at characterizing the cognitive and psycho-social long-term consequences of this rare disease Our main hypothesis is that NMDAR encephalitis has a persistent and clinically relevant impact on the patients long-term cognitive psychological and social well-being Furthermore we hypothesize that longterm subjective outcomes depend on both internal and external factors such as acute disease course access to post-acute care caregiver support personal coping strategies or access to health education resources and peer group support
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None